In colon cancer cells, CD58 was reported to be a strong surface marker for colorectal tumor-initiating cells and promoted the cells’ self-renewal ability by upregulating the Wnt/β-catenin pathway [16]. The gene discussed is CD58; the disease is colonic neoplasm.